Liminatus Pharma LIMN
NASDAQ LIMN
$5.16 -0.47 (-8.35%)
As of: Aug 21, 2026 · 3:59 PM EDT

Liminatus Pharma (LIMN) Property, Plant & Equipment (Net) (2024 - 2026)

Liminatus Pharma (LIMN) Property, Plant & Equipment (Net) (2024 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 1.67 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 5.46 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 1.96 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 2.06 Bn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 1.64 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 554.14 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 6.80 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 107.22 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Liminatus Pharma 256.03 Mn 256.03 Mn - 11,235.00

Historic Data

Download Data
DateValue
Mar 31, 2026 11,703.00
Mar 31, 2026 11,703.00
Dec 31, 2025 12,221.00
Dec 31, 2025 12,221.00
Sep 30, 2025 12,764.00
Sep 30, 2025 12,764.00
Jun 30, 2025 198.00
Jun 30, 2025 198.00
Dec 31, 2024 941.00
Dec 31, 2024 941.00